Cargando…

A Systematic Review of Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy

Transthyretin amyloid cardiomyopathy disease burden is increasing daily due to advancements in diagnostic and imaging modalities in the modern world. Tafamidis is one of many therapeutic options. The main objective of this review is to study the role of Tafamidis in slowing the progression of transt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Bishnu Mohan, Bohara, Narayan, Gautam, Kamal, Basnet, Madan, KC, Sistu, KC, Binod, Raut, Anuradha, Phudong, Abisha, Gautam, Jeevan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Cardiac/Thoracic/Vascular Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541744/ https://www.ncbi.nlm.nih.gov/pubmed/34703707 http://dx.doi.org/10.7759/cureus.18221

Ejemplares similares

Behcet's disease in an adult male from Nepal: A case report
por: Basnet, Madan, et al.
Publicado: (2021)

Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
por: Li, Benjamin, et al.
Publicado: (2020)

Initial Experience With Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy
por: Nakamura, Makiko, et al.
Publicado: (2020)

Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
por: Elliott, Perry, et al.
Publicado: (2021)

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy
por: Falk, Rodney H., et al.
Publicado: (2021)

Tafamidis and tafamidis meglumine for amyloid cardiomyopathy
Publicado: (2021)

Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy
por: Rettl, René, et al.
Publicado: (2023)

Systemic embolism in amyloid transthyretin cardiomyopathy
por: Vilches, Silvia, et al.
Publicado: (2022)

Ruptured Bullae: A Case of Transthyretin Cardiac Amyloidosis
por: Dayco, John, et al.
Publicado: (2021)

Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies
por: Rozenbaum, Mark H, et al.
Publicado: (2021)

Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
por: Rozenbaum, Mark H., et al.
Publicado: (2022)

Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis
por: Wang, Jie, et al.
Publicado: (2023)

Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
por: Takashio, Seiji, et al.
Publicado: (2023)

Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy
por: Romero-Imbroda, Jesús, et al.
Publicado: (2017)

Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy
por: Shintani, Yasuhiro, et al.
Publicado: (2018)

Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis
por: Vong, Camille, et al.
Publicado: (2021)

Recovery of sinus rhythm by tafamidis in patients with wild-type transthyretin amyloid cardiomyopathy with atrial arrhythmias
por: Isotani, Yoshitaka, et al.
Publicado: (2022)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis
por: Patel, Rishi K., et al.
Publicado: (2022)

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
por: Coelho, Teresa, et al.
Publicado: (2013)

Treatment With Tafamidis Slows Disease Progression in Early-Stage Transthyretin Cardiomyopathy
por: Sultan, Marla B, et al.
Publicado: (2017)

Esophagogastrectomy for Long-Segment Recurrent Esophageal Stricture Following Hyperemesis Gravidarum
por: Chong Tai, Lorraine I, et al.
Publicado: (2023)

Biventricular Takotsubo Cardiomyopathy Secondary to COVID-19
por: Casey, Bradley, et al.
Publicado: (2023)

Cardiac Angiosarcoma from a Saphenous Vein Coronary Artery Bypass Graft
por: Hartvigson, Pehr E, et al.
Publicado: (2019)

Spontaneous Pneumomediastinum in COVID-19 Pneumonia
por: Jesrani, Gautam, et al.
Publicado: (2021)

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study
por: Damy, Thibaud, et al.
Publicado: (2020)

Peripheral Thromboembolism Formation in a Case of Takotsubo Cardiomyopathy
por: Patel, Reema S, et al.
Publicado: (2022)

A Case of Takotsubo Cardiomyopathy After Mitral Valvuloplasty
por: Nakajima, Tomohiro, et al.
Publicado: (2023)

Rupture of Both Left-Sided Valves Following Endocarditis Causing One Trouble After Another: A Case Report
por: Khoury, Mtanis, et al.
Publicado: (2022)

Polymicrobial Prosthetic Valve Endocarditis Due to Neisseria gonorrhoeae and Pseudomonas fluorescens in a Patient With Tetralogy of Fallot: A Case Report
por: Edwards, Matthew K, et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Takotsubo Cardiomyopathy Triggered by the Death of Pets (Cats): Two Case Reports
por: Hanif, Muhammad, et al.
Publicado: (2020)

5-Fluorouracil Induced Takotsubo Cardiomyopathy Complicated by Left Ventricular Thrombosis
por: Kumar, Dilpat, et al.
Publicado: (2021)

Arrhythmogenic Cardiomyopathy: A Review of a Rare Case of Biventricular Phenotype
por: Aiwuyo, Henry O, et al.
Publicado: (2022)

An Unusual Presentation of Apical Hypertrophic Cardiomyopathy in an Orthotopic Heart Transplant Recipient
por: Molina-Lopez, Victor H, et al.
Publicado: (2023)

Longevity in a Patient With Hypertrophic Cardiomyopathy, Anomalous Coronary Artery, and Gastrointestinal Bleeding
por: Myadam, Rahul, et al.
Publicado: (2020)

An Overlooked Cause of Myocardial Infarction With Normal Coronaries Presenting as Stress Cardiomyopathy in Females
por: Singh, Annapoorna, et al.
Publicado: (2023)

Subaortic Membrane Mimicking Hypertrophic Cardiomyopathy in the Setting of Mitral Valve Infective Endocarditis
por: Polina, Aws, et al.
Publicado: (2023)

The Grave Consequences of Late Presentation and Management of Rare Double Left Ventricle Chamber With Cardiomyopathy
por: Al-Musawi, Mohammed, et al.
Publicado: (2020)

Left Ventricle Non-Compaction Cardiomyopathy Admitted With Multiorgan Failure: A Case Report
por: Álvarez Pérez, Luis F, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jn81v64r8taup75i8d3lchfl20